Patients’ characteristics at 10-year follow-up divided into the three primary treatment groups
| 0 CS injection | 1 CS injection | 2 CS injections | |
| n | 20 | 43 | 13 |
| Female | 4 | 24 | 7 |
| Age (SD) | 56 (10.8) | 60 (11.5) | 58 (9.4) |
| Weight (SD) | 83.9 (13.7) | 76.0 (14.7) | 83.2 (10.2) |
| Change of sport during 10 years | 8 | 20 | 6 |
| Due to Achilles tendon | 4 | 9 | 4 |
| Other treatment past 10 years | |||
| Operation | 1 | 8 | 3 |
| CS injection | 3 | 1 | 2 |
| Other | 1 | 4 | 3 |
| Physical function past 10 years | (19 answers) | (43 answers) | (13 answers) |
| Excellent: no limitations | 13 (68%) | 29 (67%) | 5 (38%) |
| Good: slight limitation | 5 (26%) | 12 (28%) | 3 (23%) |
| Fair: large physical limitation | 0 (0%) | 2 (5%) | 5 (38%) |
| Poor: severe physical limitation | 1 (5%) | 0 (0%) | 0 (0%) |
| Activity level compared with preinjury level | (19 answers) | (43 answers) | (13 answers) |
| 0%–24% | 1 (5%) | 2 (5%) | 1 (8%) |
| 25%–49% | 1 (5%) | 3 (7%) | 1 (8%) |
| 50%–74% | 2 (11%) | 3 (7%) | 4 (31%) |
| 75%–100% | 15 (79%) | 35 (81%) | 7 (54%) |
| VISA-A score | (19 answers) | (43 answers) | (13 answers) |
| 0–49 | 1 (5%) | 1 (2%) | 4 (31%) |
| 50–74 | 1 (5%) | 9 (21%) | 0 (0%) |
| 75–89 | 4 (21%) | 6 (14%) | 1 (8%) |
| 90–100 | 13 (68%) | 27 (63%) | 8 (62%) |
CS, corticosteroid; VISA-A, Victorian Institute of Sports Assessment-Achilles.